NCT00859105 - A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis | Biotech Hunter

Enrollment

497

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2008

Conditions

Actinic Keratosis

Interventions

DRUG

Imiquimod 5%: manufactured by Apotex

Treatment applied as a thin layer to target area once a day, 2 days each week, 16 weeks

DRUG

Adara 5% Cream US

Treatment applied as a thin layer to target area once a day, 2 days each week, for 16 weeks

DRUG

Adara 5% Cream Canada

Treatment applied as a thin layer to target area once a day, 2 days each week, for 16 weeks.

DRUG

Imiquimod Vehicle

Treatment applied as a thin layer to target area once a day, 2 days each week, for 16 weeks